Bestaande gebruiker? Log in
Abonneren
Home
Beurs vandaag
Koersen
Nieuws
Agenda
Analisten
Analisten vandaag
Meest aanbevolen aandelen
Minst aanbevolen aandelen
Aandelen met grootste potentieel
Insider trading
Insiders vandaag
Meest gekochte aandelen
Meest verkochte aandelen
Mijn Trivano
Mijn Trivano
Mijn selecties
Mijn nieuwsbrieven
Abonneren
Beurs vandaag
Koersen
Nieuws
Agenda
Analisten
Insider trading
Mijn Trivano
Registreren / inloggen
Beurs vandaag
Quest Diagnostics, Inc.
Nieuws
Quest Diagnostics, Inc.
DGX
NYS
: DGX
| ISIN: US74834L1008
14/02/2025
168,77 USD
(+0,03%)
(+0,03%)
14/02/2025
Aandeel volgen
Aandeel gevolgd
Samenvatting
Nieuws
Insiders
Dividend
Technische analyse
TA
Toon enkel gratis nieuws
28 augustus 2024 ·
Quest Diagnostics to Speak at the Morgan Stanley 22nd Annual Global Healthcare Conference
· Persbericht
26 augustus 2024 ·
Quest Diagnostics Completes Acquisition of LifeLabs, Enhancing Access to Diagnostic Innovation
· Persbericht
21 augustus 2024 ·
Quest Diagnostics to Acquire University Hospitals' Outreach Laboratory Services Business
· Persbericht
16 augustus 2024 ·
Quest Diagnostics Prices $1.85 Billion of Senior Notes
· Persbericht
15 augustus 2024 ·
questhealth.com Introduces 13 New Blood Tests to Identify Micronutrient Deficiencies
· Persbericht
15 augustus 2024 ·
Quest Diagnostics Declares Quarterly Cash Dividend
· Persbericht
12 augustus 2024 ·
Pregnant Women Undertested for STIs, Finds Quest Diagnostics Health Trends® Study of Over 4 Million Pregnancies
· Persbericht
1 augustus 2024 ·
Quest Diagnostics Named a "Best Place to Work for Disability Inclusion" for Seventh Straight Year
· Persbericht
29 juli 2024 ·
Haystack Oncology and Université de Montréal's affiliated hospital research centre, the CRCHUM, to Deploy Haystack MRD™ Technology in Research Study for Metastatic Colorectal Cancer
· Persbericht
25 juli 2024 ·
BD, Quest Diagnostics Join Forces to Develop Companion Diagnostics for Cancer, Other Diseases
· Persbericht
23 juli 2024 ·
Quest Diagnostics Reports Second Quarter 2024 Financial Results; Raises Guidance for Full Year 2024
· Persbericht
10 juli 2024 ·
Quest Diagnostics to Acquire Outreach Laboratory Services of OhioHealth
· Persbericht
3 juli 2024 ·
Quest Diagnostics to Acquire LifeLabs from OMERS, Enhancing Diagnostic Services for Canadians
· Persbericht
27 juni 2024 ·
Quest Diagnostics Releases 2023 Corporate Responsibility Report
· Persbericht
26 juni 2024 ·
Quest Diagnostics to Acquire Select Lab Assets from Allina Health
· Persbericht
19 juni 2024 ·
Quest Diagnostics to Release Second Quarter 2024 Financial Results on July 23, 2024
· Persbericht
11 juni 2024 ·
Quest Diagnostics Completes Acquisition of Select PathAI Diagnostics' Lab Assets from PathAI, Accelerating Adoption of AI and Digital Pathology to Speed Cancer Diagnosis
· Persbericht
31 mei 2024 ·
Blood-based MRD Test for Cancer Recurrence Can Generate Cost Savings in Colorectal Cancer Treatment, Finds Study in JAMA Health Forum
· Persbericht
16 mei 2024 ·
Quest Diagnostics Elects Robert B. Carter, CIO of FedEx Corporation, to Board of Directors
· Persbericht
15 mei 2024 ·
Quest Diagnostics Declares Quarterly Cash Dividend
· Persbericht
Aandeel volgen
Aandeel gevolgd
Mijn selecties
Voorbeeldselectie
Je selectie is nog leeg.
Voeg nu effecten toe